Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 29, 2025

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

722

Current outstanding challenges in germ cell tumors.

Tareq Salous1, Nabil Adra

  • 1Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, USA.

Current Opinion in Oncology
|April 4, 2024
PubMed
Summary

Germ cell tumor (GCT) treatment advances continue, but challenges persist, especially for poor-risk patients and those with refractory disease. Multidisciplinary care at specialized centers is crucial for optimal management of these complex GCT cases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary Mediastinal Seminoma: Clinical Characteristics and Outcomes.

Clinical genitourinary cancer·2026
Same author

How to Optimize Treatment for Patients With Poor-Risk Testicular Cancer.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting·2026
Same author

NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Quantitative Assessment of Seminoma in the Testicle Among Nonseminomatous Germ Cell Tumor Patients on Operative Difficulty, Morbidity and Pathological Outcomes at Postchemotherapy RPLND.

Clinical genitourinary cancer·2026
Same author

Recent developments and outstanding challenges in germ cell tumors.

Current opinion in oncology·2026
Same author

Erratum: Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors.

JCO precision oncology·2026

Area of Science:

  • Oncology
  • Cancer Research
  • Genitourinary Cancers

Background:

  • Despite significant progress in germ cell tumor (GCT) treatment, critical challenges impede optimal patient outcomes.
  • Certain patient subgroups, including those with International Germ Cell Cancer Collaborative Group poor-risk disease or platinum-refractory GCTs, face a poor prognosis.

Approach:

  • This review synthesizes current knowledge on persistent challenges in GCT management.
  • It emphasizes the need for novel therapeutic strategies and diagnostic biomarkers.
  • Highlights the importance of a multidisciplinary approach for complex cases, such as those with brain metastases.

Key Points:

  • Investigating novel therapeutic interventions is essential for patients with poor-risk GCT.
  • A multidisciplinary approach is vital for managing GCT patients with brain metastases.

More Related Videos

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

2.5K
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
09:36

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

10.3K

Related Experiment Videos

Last Updated: Jun 29, 2025

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

722
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
09:06

Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma

Published on: November 11, 2021

2.5K
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
09:36

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

10.3K
  • Development of novel biomarkers for minimal residual disease or teratoma detection is needed.
  • Conventional tumor markers (AFP, hCG) remain standard, but improved detection methods are required.

    • Conclusions:

    • Effective management of germ cell tumors necessitates a collaborative, multidisciplinary approach.
    • Patients with GCT should ideally receive care at tertiary centers with specialized expertise.
    • Continued research into novel treatments and biomarkers is critical for improving GCT patient survival and care.